ATE1-AS1: A Potential Drug Target and Biomarker (G100130887)

Target Name: ATE1-AS1

NCBI ID: G100130887

ATE1-AS1

Other Name(s): ATE1 antisense RNA 1 | ATE1OSP | ATE1 opposite strand, pseudogene

ATE1-AS1: A Potential Drug Target and Biomarker

ATE1-AS1 is a protein that is expressed in various tissues, including the brain, heart, and kidneys, and is involved in the regulation of cell survival and growth. The discovery of this protein has raised the possibility that it may be a drug target or biomarker for various diseases. In this article, we will explore the potential drug targets and biomarkers of ATE1-AS1, and discuss the current research on this protein.

Potential Drug Targets

ATE1-AS1 has been shown to play a role in several cellular processes that are crucial for the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Here are some of the potential drug targets of ATE1-AS1:

1. Cellular apoptosis

ATE1-AS1 has been shown to be involved in the regulation of cellular apoptosis, which is a natural process that helps the body eliminate damaged or dysfunctional cells. research has shown that ATE1-AS1 plays a role in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, by regulating the apoptosis of brain cells.

2. Cellular signaling

ATE1-AS1 is involved in several cellular signaling pathways that are crucial for the growth and survival of cells. One of the most significant signaling pathways that ATE1-AS1 is involved in is the TGF-β pathway, which is involved in cell growth, differentiation, and survival.

3. Cellular inflammation

ATE1-AS1 has been shown to be involved in the regulation of cellular inflammation, which is a critical part of the immune response. research has shown that ATE1-AS1 plays a role in the development of inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease.

Potential Biomarkers

ATE1-AS1 has also been shown to be involved in the regulation of several physiological processes that are important for the health and function of the body. Here are some of the potential biomarkers for ATE1-AS1:

1. Cellular stress

Research has shown that ATE1-AS1 is involved in the regulation of cellular stress, which is a critical factor in the development and progression of stress-related diseases, such as anxiety and depression.

2. Cellular metabolism

ATE1-AS1 is involved in the regulation of cellular metabolism, which is crucial for the growth and survival of cells. research has shown that ATE1-AS1 plays a role in the development and progression of diseases that are characterized by cellular metabolism disorders, such as obesity and type 2 diabetes.

3. Cellular immune response

ATE1-AS1 is involved in the regulation of the cellular immune response, which is crucial for the development and regulation of an effective immune response against infections and diseases. research has shown that ATE1-AS1 plays a role in the development and progression of diseases that are characterized by an imbalance in the cellular immune response, such as cancer and autoimmune disorders.

Conclusion

In conclusion, ATE1-AS1 is a protein that is involved in several cellular processes that are crucial for the development and progression of various diseases. The potential drug targets and biomarkers for ATE1-AS1 have been identified, and research is ongoing to determine its role in the regulation of these processes. Further research is needed to understand the full potential of ATE1-AS1 as a drug target and biomarker.

Protein Name: ATE1 Antisense RNA 1

The "ATE1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ATE1-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets